chr2-88595605-T-C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_004836.7(EIF2AK3):​c.497A>G​(p.Gln166Arg) variant causes a missense change. The variant allele was found at a frequency of 0.658 in 1,613,308 control chromosomes in the GnomAD database, including 353,757 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.70 ( 38451 hom., cov: 31)
Exomes 𝑓: 0.65 ( 315306 hom. )

Consequence

EIF2AK3
NM_004836.7 missense

Scores

1
17

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:12

Conservation

PhyloP100: 5.57

Publications

54 publications found
Variant links:
Genes affected
EIF2AK3 (HGNC:3255): (eukaryotic translation initiation factor 2 alpha kinase 3) The protein encoded by this gene phosphorylates the alpha subunit of eukaryotic translation-initiation factor 2, leading to its inactivation, and thus to a rapid reduction of translational initiation and repression of global protein synthesis. This protein is thought to modulate mitochondrial function. It is a type I membrane protein located in the endoplasmic reticulum (ER), where it is induced by ER stress caused by malfolded proteins. Mutations in this gene are associated with Wolcott-Rallison syndrome. [provided by RefSeq, Sep 2015]
EIF2AK3 Gene-Disease associations (from GenCC):
  • Wolcott-Rallison syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Ambry Genetics, Genomics England PanelApp, G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=6.14049E-7).
BP6
Variant 2-88595605-T-C is Benign according to our data. Variant chr2-88595605-T-C is described in ClinVar as Benign. ClinVar VariationId is 128988.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.854 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
EIF2AK3NM_004836.7 linkc.497A>G p.Gln166Arg missense_variant Exon 3 of 17 ENST00000303236.9 NP_004827.4 Q9NZJ5B3KY45
EIF2AK3NM_001313915.2 linkc.44A>G p.Gln15Arg missense_variant Exon 3 of 17 NP_001300844.1 A0A804HIT4Q68DI6
EIF2AK3XM_047446428.1 linkc.206A>G p.Gln69Arg missense_variant Exon 3 of 17 XP_047302384.1
EIF2AK3XM_047446430.1 linkc.497A>G p.Gln166Arg missense_variant Exon 3 of 12 XP_047302386.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
EIF2AK3ENST00000303236.9 linkc.497A>G p.Gln166Arg missense_variant Exon 3 of 17 1 NM_004836.7 ENSP00000307235.3 Q9NZJ5

Frequencies

GnomAD3 genomes
AF:
0.703
AC:
106666
AN:
151836
Hom.:
38408
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.862
Gnomad AMI
AF:
0.656
Gnomad AMR
AF:
0.623
Gnomad ASJ
AF:
0.731
Gnomad EAS
AF:
0.490
Gnomad SAS
AF:
0.528
Gnomad FIN
AF:
0.592
Gnomad MID
AF:
0.687
Gnomad NFE
AF:
0.669
Gnomad OTH
AF:
0.672
GnomAD2 exomes
AF:
0.632
AC:
158568
AN:
250952
AF XY:
0.628
show subpopulations
Gnomad AFR exome
AF:
0.870
Gnomad AMR exome
AF:
0.576
Gnomad ASJ exome
AF:
0.727
Gnomad EAS exome
AF:
0.468
Gnomad FIN exome
AF:
0.592
Gnomad NFE exome
AF:
0.667
Gnomad OTH exome
AF:
0.641
GnomAD4 exome
AF:
0.654
AC:
955218
AN:
1461354
Hom.:
315306
Cov.:
52
AF XY:
0.651
AC XY:
473352
AN XY:
726994
show subpopulations
African (AFR)
AF:
0.873
AC:
29242
AN:
33478
American (AMR)
AF:
0.581
AC:
25996
AN:
44718
Ashkenazi Jewish (ASJ)
AF:
0.721
AC:
18839
AN:
26128
East Asian (EAS)
AF:
0.522
AC:
20700
AN:
39656
South Asian (SAS)
AF:
0.535
AC:
46133
AN:
86240
European-Finnish (FIN)
AF:
0.597
AC:
31884
AN:
53394
Middle Eastern (MID)
AF:
0.693
AC:
3998
AN:
5768
European-Non Finnish (NFE)
AF:
0.664
AC:
738413
AN:
1111608
Other (OTH)
AF:
0.663
AC:
40013
AN:
60364
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.471
Heterozygous variant carriers
0
18131
36263
54394
72526
90657
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
19056
38112
57168
76224
95280
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.703
AC:
106758
AN:
151954
Hom.:
38451
Cov.:
31
AF XY:
0.694
AC XY:
51544
AN XY:
74258
show subpopulations
African (AFR)
AF:
0.862
AC:
35743
AN:
41468
American (AMR)
AF:
0.622
AC:
9494
AN:
15252
Ashkenazi Jewish (ASJ)
AF:
0.731
AC:
2533
AN:
3466
East Asian (EAS)
AF:
0.490
AC:
2529
AN:
5160
South Asian (SAS)
AF:
0.526
AC:
2529
AN:
4804
European-Finnish (FIN)
AF:
0.592
AC:
6233
AN:
10532
Middle Eastern (MID)
AF:
0.687
AC:
202
AN:
294
European-Non Finnish (NFE)
AF:
0.669
AC:
45485
AN:
67958
Other (OTH)
AF:
0.670
AC:
1413
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
1500
3000
4500
6000
7500
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
806
1612
2418
3224
4030
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.680
Hom.:
139115
Bravo
AF:
0.715
TwinsUK
AF:
0.656
AC:
2434
ALSPAC
AF:
0.663
AC:
2555
ESP6500AA
AF:
0.865
AC:
3811
ESP6500EA
AF:
0.668
AC:
5745
ExAC
AF:
0.637
AC:
77366
Asia WGS
AF:
0.564
AC:
1963
AN:
3478
EpiCase
AF:
0.684
EpiControl
AF:
0.681

ClinVar

Significance: Benign
Submissions summary: Benign:12
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:4
-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Jan 21, 2015
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Genetic Services Laboratory, University of Chicago
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed. -

Wolcott-Rallison dysplasia Benign:4
May 28, 2019
Mendelics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Jul 30, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

not provided Benign:3
Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Nov 11, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 24032041) -

Connective tissue disorder Benign:1
Jul 18, 2022
Genome Diagnostics Laboratory, The Hospital for Sick Children
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.048
BayesDel_addAF
Benign
-0.69
T
BayesDel_noAF
Benign
-0.62
CADD
Benign
19
DANN
Benign
0.82
DEOGEN2
Benign
0.080
.;T;.
Eigen
Benign
-0.68
Eigen_PC
Benign
-0.30
FATHMM_MKL
Benign
0.26
N
LIST_S2
Benign
0.20
.;T;.
MetaRNN
Benign
6.1e-7
T;T;T
MetaSVM
Benign
-0.95
T
MutationAssessor
Benign
-2.0
.;N;.
PhyloP100
5.6
PrimateAI
Uncertain
0.74
T
PROVEAN
Benign
0.81
N;N;N
REVEL
Benign
0.14
Sift
Benign
0.92
T;T;T
Sift4G
Benign
0.98
T;T;.
Polyphen
0.0
.;B;.
Vest4
0.057
MPC
0.36
ClinPred
0.013
T
GERP RS
6.2
PromoterAI
0.020
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.34
gMVP
0.67
Mutation Taster
=90/10
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs13045; hg19: chr2-88895123; COSMIC: COSV57548059; COSMIC: COSV57548059; API